{"id":"W2968942240","doi":"10.1182/blood.2019000324","title":"Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"Pembrolizumab; Medicine; Refractory (planetary science); Lymphoma; Internal medicine; Oncology; Hodgkin lymphoma; Cancer; Immunotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002330913,0.000387994,0.001014379,0.000802558,0.0005409564,0.0009077257,0.0003732163,0.0007912619,0.0007629319],"category_scores_gemma":[0.002623674,0.0002842894,0.0009681309,0.0006512573,0.0002146758,0.0008057764,0.0005677917,0.001012255,0.0003511293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006667341,"about_ca_system_score_gemma":0.0003114197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001787851,"about_ca_topic_score_gemma":0.001708503,"domain_scores_codex":[0.9992342,0.0002256758,0.00008424029,0.0001606098,0.0001557156,0.0001395691],"domain_scores_gemma":[0.9980737,0.0003887914,0.0007196698,0.0001952717,0.0003174056,0.0003050626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0166652,0.0008255565,0.9467216,0.0001156975,0.001010697,0.0008189734,0.0003128049,0.0005514617,0.003085591,0.00005110428,0.0009481788,0.02889311],"study_design_scores_gemma":[0.000473488,0.003990577,0.9912949,0.0000262797,0.0007114536,0.0006465061,0.0001005947,0.0005789342,0.0007219231,0.00004930297,0.001382998,0.00002322409],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962727,0.00173969,0.0001610271,0.00005655937,0.00001376483,0.00005415255,0.0009383571,0.0000136864,0.000750037],"genre_scores_gemma":[0.9966903,0.0003275591,0.00009228686,0.0000888427,0.00002382426,0.00003758728,0.002427814,0.000003808567,0.0003079825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002330913,"threshold_uncertainty_score":0.01232719,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01353759303662356,"score_gpt":0.2492147533128331,"score_spread":0.2356771602762095,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}